A H Schapira. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Antiparkinson Agents/administration & dosageAntiparkinson Agents/adverse effectsBrain/blood supplyBrain/pathologyBrain/physiopathologyCognition Disorders/diagnosisCognition Disorders/physiopathologyDopamine/metabolismDopamine Agents/administration & dosageDopamine Agents/adverse effectsEarly DiagnosisHumansLewy Body Disease/diagnosisLewy Body Disease/physiopathologyNeuropharmacology/trendsParkinson Disease/diagnosisParkinson Disease/drug therapyParkinson Disease/physiopathology
Substances: See more » Antiparkinson AgentsDopamine AgentsDopamine
Year: 2008 PMID: 18171385 DOI: 10.1111/j.1468-1331.2007.02036.x
Source DB: PubMed Journal: Eur J Neurol ISSN: 1351-5101 Impact factor: 6.089